354 related articles for article (PubMed ID: 11402222)
21. [Impact of reverse transcriptase inhibitors on sperm mitochondrial and genomic DNA in assisted reproduction techniques].
Sergerie M; Martinet S; Kiffer N; Teulé R; Pasquier C; Bujan L
Gynecol Obstet Fertil; 2004 Oct; 32(10):841-9. PubMed ID: 15501159
[TBL] [Abstract][Full Text] [Related]
22. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
Viganò A; Giacomet V
Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
[No Abstract] [Full Text] [Related]
23. Antiretroviral nucleoside and nucleotide analogues and mitochondria.
Cossarizza A; Moyle G
AIDS; 2004 Jan; 18(2):137-51. PubMed ID: 15075530
[No Abstract] [Full Text] [Related]
24. Mitochondrial abnormalities in HIV-infected lipoatrophic patients treated with antiretroviral agents.
Chapplain JM; Beillot J; Begue JM; Souala F; Bouvier C; Arvieux C; Tattevin P; Dupont M; Chapon F; Duvauferrier R; Hespel JP; Rochcongar P; Michelet C
J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1477-88. PubMed ID: 15602126
[TBL] [Abstract][Full Text] [Related]
25. [Lactic acidosis in HIV-patients--diagnosis and treatment].
Walker UA
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():65-7. PubMed ID: 15373054
[TBL] [Abstract][Full Text] [Related]
26. HIV and mitochondrial toxicity in children.
Foster C; Lyall H
J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy.
Lewis W
Prog Cardiovasc Dis; 2003; 45(4):305-18. PubMed ID: 12638094
[TBL] [Abstract][Full Text] [Related]
28. HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies.
Gardner K; Hall PA; Chinnery PF; Payne BA
Toxicol Pathol; 2014 Jul; 42(5):811-22. PubMed ID: 24067671
[TBL] [Abstract][Full Text] [Related]
29. Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.
Koczor CA; Lewis W
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1493-504. PubMed ID: 20929279
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.
Ciccosanti F; Corazzari M; Soldani F; Matarrese P; Pagliarini V; Iadevaia V; Tinari A; Zaccarelli M; Perfettini JL; Malorni W; Kroemer G; Antinori A; Fimia GM; Piacentini M
Antivir Ther; 2010; 15(3):377-90. PubMed ID: 20516557
[TBL] [Abstract][Full Text] [Related]
31. Lactic Acidosis Complicating Metformin and Non-Nucleoside Reverse Transcriptase Inhibitor Combination Therapy: A Smoldering Threat in the Post-HAART Era.
Ortiz-Brizuela E; Pérez-Patrigeon S; Recillas-Gispert C; Gómez-Pérez FJ
Rev Invest Clin; 2015; 67(4):273-4. PubMed ID: 26426594
[TBL] [Abstract][Full Text] [Related]
32. An introduction to nucleoside and nucleotide analogues.
Squires KE
Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
[TBL] [Abstract][Full Text] [Related]
33. Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan.
Sheng WH; Hsieh SM; Lee SC; Chen MY; Wang JT; Hung CC; Chang SC
Int J STD AIDS; 2004 Apr; 15(4):249-53. PubMed ID: 15075019
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapy.
Tolomeo M; Mancuso S; Todaro M; Stassi G; Catalano M; Arista S; Cannizzo G; Barbusca E; Abbadessa V
J Clin Pathol; 2003 Feb; 56(2):147-51. PubMed ID: 12560398
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial studies in HAART-related lipodystrophy: from experimental hypothesis to clinical findings.
Miró O; López S; Cardellach F; Casademont J
Antivir Ther; 2005; 10 Suppl 2():M73-81. PubMed ID: 16152708
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial dysfunction: patient monitoring and toxicity management.
McComsey G; Lonergan JT
J Acquir Immune Defic Syndr; 2004 Sep; 37 Suppl 1():S30-5. PubMed ID: 15319667
[TBL] [Abstract][Full Text] [Related]
37. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
Brinkman K
J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
[No Abstract] [Full Text] [Related]
38. Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort.
Liu K; Sun Y; Liu D; Yin J; Qiao L; Shi Y; Dong Y; Li N; Zhang F; Chen D
PLoS One; 2013; 8(2):e57223. PubMed ID: 23468942
[TBL] [Abstract][Full Text] [Related]
39. A brief review on human mtDNA mutations and NRTI-associated mtDNA toxicity and mutations.
Chattopadhyay K; Aldous C
Mitochondrial DNA A DNA Mapp Seq Anal; 2016 May; 27(3):1685-7. PubMed ID: 25211089
[TBL] [Abstract][Full Text] [Related]
40. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.
Nolan D; Hammond E; James I; McKinnon E; Mallal S
Antivir Ther; 2003 Dec; 8(6):617-26. PubMed ID: 14760896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
